Skip to main content
Erschienen in: Pathology & Oncology Research 2/2019

02.02.2019 | Review

Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma – a Systematic Review with Meta Analysis

verfasst von: K. Hema Shree, Pratibha Ramani, Herald Sherlin, Gheena Sukumaran, Gifrrina Jeyaraj, K. R. Don, Archana Santhanam, Abilasha Ramasubramanian, R. Sundar

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Whole saliva is mainly composed of fluid produced by major and minor salivary glands. Major salivary glands including parotid, submandibular, and sublingual glands, are known to secrete fluid transported from serum as well as surrounding glandular tissues [1]. Beside the secretions from salivary glands, oral mucosa, periodontium, as well as oral microflora also contribute to the final content of whole saliva [1]. Whole saliva therefore represents a complex balance among local and systemic sources [2]. This allows for the application of saliva in the diagnosis not only for salivary gland disorders but also for oral diseases and systemic conditions [2]. The role of saliva as a diagnostic tool in detecting Oral Squamous Cell Carcinoma. Articles published in PUBMED, EMBASE, COCHRANE, GOOGLE, manual search and back references of the articles for last 5 years extracted 77 articles. Studies which considered saliva as a diagnostic tool were included. Statistical analysis with Receivers Operating Curve to establish sensitivity and specificity of the salivary biomarkers as a diagnostic tool to detect Oral Squamous Cell Carcinoma were included for meta analysis. The measure of effect with 95% confidence interval were meta analysed for 9 articles in which 308 healthy individuals compared with 340 patients with Oral Squamous Cell Carcinoma. Highly sensitive salivary biomarkers for detecting Oral Squamous Cell Carcinoma were MMP-9, Chemerin, Choline + Betaine + Pipecolinic Acid + I – Carnitine(confidence interval ranges from 0.83–1.0). The narrow confidence interval of 0.95 + (0.88–1.00) was seen for MMP-9 followed by 1.00 + (0.78–1.00) for chemerin. Highly specific biomarkers for Oral Squamous Cell Carcinoma were MMP-9 (specificity −100%,), Chemerin(specificity-100%), over expressed mi RNA 136 with specificity of 0.88(0.69–0.97), under expressed mi RNA 27B with specificity of 1.0(0.66–1.00). Saliva can be used as a diagnostic tool with highly sensitive and specific markers namely MMP-9, Chemerin for early detection of Oral Squamous Cell Carcinoma.
Literatur
1.
Zurück zum Zitat Caporossi L, Santoro A, Papaleo B (2010 Sep) Saliva as an analytical matrix: state of the art and application for biomonitoring. Biomark Biochem Indic Expo Response Susceptibility Chem 15(6):475–487 Caporossi L, Santoro A, Papaleo B (2010 Sep) Saliva as an analytical matrix: state of the art and application for biomonitoring. Biomark Biochem Indic Expo Response Susceptibility Chem 15(6):475–487
2.
Zurück zum Zitat Good DM, Thongboonkerd V, Novak J, Bascands J-L, Schanstra JP, Coon JJ, Dominiczak A, Mischak H (2007 Dec) Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 6(12):4549–4555CrossRefPubMed Good DM, Thongboonkerd V, Novak J, Bascands J-L, Schanstra JP, Coon JJ, Dominiczak A, Mischak H (2007 Dec) Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 6(12):4549–4555CrossRefPubMed
4.
Zurück zum Zitat Malamud D, Rodriguez-Chavez IR (2011 Jan) Saliva as a Diagnostic Fluid. Dent Clin N Am 55(1):159–178CrossRefPubMed Malamud D, Rodriguez-Chavez IR (2011 Jan) Saliva as a Diagnostic Fluid. Dent Clin N Am 55(1):159–178CrossRefPubMed
5.
Zurück zum Zitat Radhika T, Jeddy N, Nithya S, Muthumeenakshi RM (2016 Nov) Salivary biomarkers in oral squamous cell carcinoma – an insight. J Oral Biol Craniofacial Res 6(Suppl 1):S51–S54CrossRef Radhika T, Jeddy N, Nithya S, Muthumeenakshi RM (2016 Nov) Salivary biomarkers in oral squamous cell carcinoma – an insight. J Oral Biol Craniofacial Res 6(Suppl 1):S51–S54CrossRef
6.
Zurück zum Zitat Gualtero DF, Castillo AS (2016 Apr 2) Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review. Acta Odontol Scand 74(3):170–177CrossRefPubMed Gualtero DF, Castillo AS (2016 Apr 2) Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review. Acta Odontol Scand 74(3):170–177CrossRefPubMed
7.
Zurück zum Zitat Lee LT, Wong YK, Hsiao HY, Wang YW, Chan MY, Chang KW (2017 Nov 27) Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg Lee LT, Wong YK, Hsiao HY, Wang YW, Chan MY, Chang KW (2017 Nov 27) Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg
8.
Zurück zum Zitat Ghallab NA, Shaker OG (2017 Apr) Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig 21(3):937–947CrossRefPubMed Ghallab NA, Shaker OG (2017 Apr) Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig 21(3):937–947CrossRefPubMed
9.
Zurück zum Zitat Malhotra R, Urs AB, Chakravarti A, Kumar S, Gupta VK, Mahajan B (2016 Jul) Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumour Biol J Int Soc Oncodevelopmental Biol Med 37(7):9263–9271CrossRef Malhotra R, Urs AB, Chakravarti A, Kumar S, Gupta VK, Mahajan B (2016 Jul) Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumour Biol J Int Soc Oncodevelopmental Biol Med 37(7):9263–9271CrossRef
10.
Zurück zum Zitat Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C (2015 Sep) Salivary microRNAs in oral cancer. Oral Dis 21(6):739–747CrossRefPubMed Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C (2015 Sep) Salivary microRNAs in oral cancer. Oral Dis 21(6):739–747CrossRefPubMed
11.
Zurück zum Zitat Rajkumar K, Nandhini G, Ramya R, Rajashree P, Kumar AR, Anandan SN (2014 Sep) Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity. Oral Surg Oral Med Oral Pathol Oral Radiol 118(3):309–319CrossRefPubMed Rajkumar K, Nandhini G, Ramya R, Rajashree P, Kumar AR, Anandan SN (2014 Sep) Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity. Oral Surg Oral Med Oral Pathol Oral Radiol 118(3):309–319CrossRefPubMed
12.
Zurück zum Zitat Wang Q, Gao P, Cheng F, Wang X, Duan Y (2014 Feb) Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry. Talanta 119:299–305CrossRefPubMed Wang Q, Gao P, Cheng F, Wang X, Duan Y (2014 Feb) Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry. Talanta 119:299–305CrossRefPubMed
13.
Zurück zum Zitat Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS (2014 Jul) Genomewide study of salivary MicroRNAs for detection of Oral Cancer. J Dent Res 93(7 Suppl):86S–93SCrossRefPubMedPubMedCentral Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS (2014 Jul) Genomewide study of salivary MicroRNAs for detection of Oral Cancer. J Dent Res 93(7 Suppl):86S–93SCrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Rajkumar K, Ramya R, Nandhini G, Rajashree P, Ramesh Kumar A, Nirmala Anandan S (2015 Jan) Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Oral Dis 21(1):90–96CrossRefPubMed Rajkumar K, Ramya R, Nandhini G, Rajashree P, Ramesh Kumar A, Nirmala Anandan S (2015 Jan) Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Oral Dis 21(1):90–96CrossRefPubMed
15.
Zurück zum Zitat Wang Q, Gao P, Wang X, Duan Y (2014 Jan 1) Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta Int J Clin Chem 427:79–85CrossRef Wang Q, Gao P, Wang X, Duan Y (2014 Jan 1) Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta Int J Clin Chem 427:79–85CrossRef
16.
Zurück zum Zitat Castagnola M, Scarano E, Passali GC, Messana I, Cabras T, Iavarone F, di Cintio G, Fiorita A, de Corso E, Paludetti G (2017 Apr) Salivary biomarkers and proteomics: future diagnostic and clinical utilities. Acta Otorhinolaryngol Ital 37(2):94–101PubMedPubMedCentral Castagnola M, Scarano E, Passali GC, Messana I, Cabras T, Iavarone F, di Cintio G, Fiorita A, de Corso E, Paludetti G (2017 Apr) Salivary biomarkers and proteomics: future diagnostic and clinical utilities. Acta Otorhinolaryngol Ital 37(2):94–101PubMedPubMedCentral
17.
Zurück zum Zitat Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S (2011 Jun) Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS J Integr Biol 15(6):353–361CrossRef Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S (2011 Jun) Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS J Integr Biol 15(6):353–361CrossRef
18.
Zurück zum Zitat Wang N, Wang Q-J, Feng Y, Shang W, Cai M (2013 Jul 19) Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue. Clin Oral Investig 18 Wang N, Wang Q-J, Feng Y, Shang W, Cai M (2013 Jul 19) Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue. Clin Oral Investig 18
20.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011 Apr) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011 Apr) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRef
21.
Zurück zum Zitat Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, et al. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer [Internet]. 2016 Apr 7 [cited 2018 Jan 5];15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823852/ Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, et al. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer [Internet]. 2016 Apr 7 [cited 2018 Jan 5];15. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC4823852/
22.
Zurück zum Zitat Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y et al (2015 Mar 10) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112(10):E1106–E1115CrossRefPubMedPubMedCentral Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y et al (2015 Mar 10) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112(10):E1106–E1115CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004 Mar 2) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999–3004CrossRefPubMedPubMedCentral Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004 Mar 2) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999–3004CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W (2011 Nov 1) Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 129(9):2207–2217CrossRefPubMed Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W (2011 Nov 1) Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 129(9):2207–2217CrossRefPubMed
26.
Zurück zum Zitat Baracos VE, Mackenzie ML (2006 Jan) Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr 136(1 Suppl):237S–242SCrossRefPubMed Baracos VE, Mackenzie ML (2006 Jan) Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr 136(1 Suppl):237S–242SCrossRefPubMed
27.
Zurück zum Zitat Jinno T, Kawano S, Maruse Y, Matsubara R, Goto Y, Sakamoto T, Hashiguchi Y, Kaneko N, Tanaka H, Kitamura R, Toyoshima T, Jinno A, Moriyama M, Oobu K, Kiyoshima T, Nakamura S (2015 May) Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma. Oncol Rep 33(5):2161–2168 Jinno T, Kawano S, Maruse Y, Matsubara R, Goto Y, Sakamoto T, Hashiguchi Y, Kaneko N, Tanaka H, Kitamura R, Toyoshima T, Jinno A, Moriyama M, Oobu K, Kiyoshima T, Nakamura S (2015 May) Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma. Oncol Rep 33(5):2161–2168
28.
Zurück zum Zitat Bickel M (1993 May) The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 64(5 Suppl):456–460PubMed Bickel M (1993 May) The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 64(5 Suppl):456–460PubMed
32.
Zurück zum Zitat Nakano Y, Kobayashi W, Sugai S, Kimura H, Yagihashil S (1999 Aug 1) Expression of tumor necrosis factor-α and Interleukin-6 in Oral squamous cell carcinoma. Jpn J Cancer Res 90(8):858–866CrossRefPubMedPubMedCentral Nakano Y, Kobayashi W, Sugai S, Kimura H, Yagihashil S (1999 Aug 1) Expression of tumor necrosis factor-α and Interleukin-6 in Oral squamous cell carcinoma. Jpn J Cancer Res 90(8):858–866CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Niemann AM, Goeroegh T, Gottschlich S, Lippert BM, Werner JA (1997 Aug) Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN). Anticancer Res 17(4B):2859–2860PubMed Niemann AM, Goeroegh T, Gottschlich S, Lippert BM, Werner JA (1997 Aug) Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN). Anticancer Res 17(4B):2859–2860PubMed
Metadaten
Titel
Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma – a Systematic Review with Meta Analysis
verfasst von
K. Hema Shree
Pratibha Ramani
Herald Sherlin
Gheena Sukumaran
Gifrrina Jeyaraj
K. R. Don
Archana Santhanam
Abilasha Ramasubramanian
R. Sundar
Publikationsdatum
02.02.2019
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2019
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00588-2

Weitere Artikel der Ausgabe 2/2019

Pathology & Oncology Research 2/2019 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.